Notification Regarding Fake Website and Counterfeit Harmful Anabolic Steroids – denikhormones.com
Phnum Penh, Cambodia May 20, 2025 (Issuewire.com) - We at Denik Pharm Co Ltd remain committed to upholding the highest standards of product integrity, authenticity, and customer trust. It has come to our attention that a fraudulent website operating under the domain www.denikhormones.com is falsely claiming affiliation with Denik Pharm Co Ltd.
Please be advised:
- Denikhormones.com is in no way associated with Denik Pharm Co Ltd.
- The products being promoted or sold via this website are counterfeit Harmful Anabolic Steroids and may pose serious health risks.
- Such unauthorized activities clearly violate intellectual property rights and endanger public safety.
We are initiating immediate legal action against the operators of denikhormones.com, along with any parties involved in the manufacturing, marketing, or distribution of these counterfeit products misusing our brand name.
We urge all customers, distributors, and healthcare professionals to ensure they purchase authentic Denik Pharm products only through our official website www.denikpharm.com or our authorized distribution network.
If you have received a suspicious product or have been contacted by this fraudulent entity, please report it without delay to [email protected].
We sincerely appreciate your cooperation in helping us protect public safety and combat counterfeiting.
For more information visit our website: www.denikpharm.com
Media Contact
More On Upworldnews ::
- Instant Online Income - How to Make Money at Home? CESUR Mining Can Help You
- Winnie W. Lee, MD: A Board-Certified Surgeon and Aesthetic Expert Blending Beauty and Wellness
- Barbara Louridas, Recognized by BestAgents.us as a 2025 Top Agent
- The Traveler Launches as an Open Travel Publication for Global Storytellers
- AGII Advances Decentralized Autonomy with Next-Gen AI, Optimizing Web3 Infrastructure for Scalable Growth
Denik Pharm Co ltd
Source :Denik Pharm Co Ltd
This article was originally published by IssueWire. Read the original article here.